Covid-19 Research

Original Article

OCLC Number/Unique Identifier:

Is Anosmia-Ageusia in COVID-19 Patients Associated with Neuro-Philic Virus Mutant and Mild Respiratory Involvement?

Medicine Group    Start Submission

Duygu Zorlu*, Ali Bulut, Lokman Hu0131zmalu0131 and Yahya Sahin

Volume4-Issue1
Dates: Received: 2023-01-15 | Accepted: 2023-01-25 | Published: 2023-01-27
Pages: 104-116

Abstract

Introduction and Objective: In COVID-19, sudden onset anosmia-ageusia can be observed in patients, regardless of other rhinologic symptoms or prominent nasal symptoms.

In our clinical follow-ups, it has drawn our attention that patients presenting with anosmia-ageusia have milder pulmonary symptoms and milder progression. It was thought that this group of patients were infected with neurosensitive SARS-CoV-2 and the study was planned based on this hypothesis. We present our results to contribute to the literature because our study may be a practical screening approach in patient follow-up, may provide predictions of disease progression, and isolation period can be determined.

Materials and Methods: The study was conducted in March 2020, by interviewing recorded patients via phone. Patients’ anosmia-ageusia characteristics, hospitalizations, and recorded Thoracic Computed Tomography (CT) reports were evaluated. The reports were analyzed by a single physician and CT positivity was reported and grouped as mild, moderate and severe.

Results: A total of 1438 patients were included in the study. Of the patients, 47.8% were male and 52.0% were male, while the mean age was 44.33 ∓ 16.01 years. In terms of educational levels, patients were found to be elementary (25.6%) and high school (20.7%) graduates at most.

Discussion and Conclusion: Hospitalization rates of patients presenting with anosmia-ageusia were lower and their disease progression were milder. We suggest that there are mainly neuro- or pulmonary-sensitive variants of the virus. This characteristic is of great importance for the long-term follow-up of these patients and predictions of complications. Patients presenting with a sudden development of anosmia-ageusia should be considered as positive patients. Quarantine and isolation periods should be extended in these patients, keeping in mind the prolonged RT-PCR positivity as well. Besides, it should be noted that these patients are more likely to develop central nervous system complications and they should be followed up.

FullText HTML FullText PDF DOI: 10.37871/jbres1654


Certificate of Publication




Copyright

© 2023 Zorlu D, et al. Distributed under Creative Commons CC-BY 4.0

How to cite this article

Zorlu D, Bulut A, Hızmalı L, Sahin Y. Is Anosmia-Ageusia in COVID-19 Patients Associated with Neuro-Philic Virus Mutant and Mild Respiratory Involvement? 2023 Jan 27; 4(1): 104-116. doi: 10.37871/ jbres1654, Article ID: JBRES1654, Available at: https://www.jelsciences.com/articles/jbres1654.pdf


Subject area(s)

References


  1. Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020 Oct;50(3):499-511. doi: 10.1007/s11239-020-02230-4. PMID: 32700024; PMCID: PMC7373848.
  2. Mondal R, Lahiri D, Deb S, Bandyopadhyay D, Shome G, Sarkar S, Paria SR, Thakurta TG, Singla P, Biswas SC. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection? J Thromb Thrombolysis. 2020 Oct;50(3):567-579. doi: 10.1007/s11239-020-02210-8. PMID: 32627126; PMCID: PMC7335630.
  3. Kanjanaumporn J, Aeumjaturapat S, Snidvongs K, Seresirikachorn K, Chusakul S. Smell and taste dysfunction in patients with SARS-CoV-2 infection: A review of epidemiology, pathogenesis, prognosis, and treatment options. Asian Pac J Allergy Immunol. 2020 Jun;38(2):69-77. doi: 10.12932/AP-030520-0826. PMID: 32563234.
  4. Mullol J, Alobid I, Mariño-Sánchez F, Izquierdo-Domínguez A, Marin C, Klimek L, Wang DY, Liu Z. The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries. Curr Allergy Asthma Rep. 2020 Aug 3;20(10):61. doi: 10.1007/s11882-020-00961-1. PMID: 32748211; PMCID: PMC7397453.
  5. Wong DKC, Gendeh HS, Thong HK, Lum SG, Gendeh BS, Saim A, Salina H. A review of smell and taste dysfunction in COVID-19 patients. Med J Malaysia. 2020 Sep;75(5):574-581. PMID: 32918429.
  6. Cetinkaya EA. Coincidence of COVID-19 Infection and Smell-Taste Perception Disorders. J Craniofac Surg. 2020 Sep;31(6):e625-e626. doi: 10.1097/SCS.0000000000006601. PMID: 32398625; PMCID: PMC7282409.
  7. Daruich A, Martin D, Bremond-Gignac D. Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): Interest of telemedicine during the pandemic context. J Fr Ophtalmol. 2020 May;43(5):389-391. doi: 10.1016/j.jfo.2020.04.002. Epub 2020 Apr 17. PMID: 32334847; PMCID: PMC7164841.
  8. Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, Kanji JN, Zelyas N, Damji KF, Solarte C. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol. 2020 Aug;55(4):e125-e129. doi: 10.1016/j.jcjo.2020.03.003. Epub 2020 Apr 2. PMID: 32284146; PMCID: PMC7124283.
  9. Casalino G, Monaco G, Di Sarro PP, David A, Scialdone A. Coronavirus disease 2019 presenting with conjunctivitis as the first symptom. Eye (Lond). 2020 Jul;34(7):1235-1236. doi: 10.1038/s41433-020-0909-x. Epub 2020 Apr 28. PMID: 32346108; PMCID: PMC7186940.
  10. Wege H, Watanabe R, ter Meulen V. Relapsing subacute demyelinating encephalomyelitis in rats during the course of coronavirus JHM infection. J Neuroimmunol. 1984 Aug;6(5):325-36. doi: 10.1016/0165-5728(84)90022-5. PMID: 6086712; PMCID: PMC7119698.
  11. Alves de Sousa F, Pinto Costa R, Xará S, Nóbrega Pinto A, Almeida E Sousa C. SARS-CoV-2 and hearing: An audiometric analysis of COVID-19 hospitalized patients. J Otol. 2021 Jul;16(3):158-164. doi: 10.1016/j.joto.2021.01.005. Epub 2021 Feb 3. PMID: 33558808; PMCID: PMC7857034.
  12. Sriwijitalai W, Wiwanitkit V. Hearing loss and COVID-19: A note. Am J Otolaryngol. 2020 May-Jun;41(3):102473. doi: 10.1016/j.amjoto.2020.102473. Epub 2020 Apr 2. PMID: 32276732; PMCID: PMC7132500.
  13. Daher A, Balfanz P, Cornelissen C, Müller A, Bergs I, Marx N, Müller-Wieland D, Hartmann B, Dreher M, Müller T. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med. 2020 Nov-Dec;174:106197. doi: 10.1016/j.rmed.2020.106197. Epub 2020 Oct 20. PMID: 33120193; PMCID: PMC7573668.
  14. Foster KJ, Jauregui E, Tajudeen B, Bishehsari F, Mahdavinia M. Smell loss is a prognostic factor for lower severity of coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020 Oct;125(4):481-483. doi: 10.1016/j.anai.2020.07.023. Epub 2020 Jul 24. PMID: 32717301; PMCID: PMC7380219.
  15. Kakodkar P, Kaka N, Baig MN. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus. 2020 Apr 6;12(4):e7560. doi: 10.7759/cureus.7560. PMID: 32269893; PMCID: PMC7138423.
  16. Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, Bonten MMJ, Dahly DL, Damen JAA, Debray TPA, de Jong VMT, De Vos M, Dhiman P, Haller MC, Harhay MO, Henckaerts L, Heus P, Kammer M, Kreuzberger N, Lohmann A, Luijken K, Ma J, Martin GP, McLernon DJ, Andaur Navarro CL, Reitsma JB, Sergeant JC, Shi C, Skoetz N, Smits LJM, Snell KIE, Sperrin M, Spijker R, Steyerberg EW, Takada T, Tzoulaki I, van Kuijk SMJ, van Bussel B, van der Horst ICC, van Royen FS, Verbakel JY, Wallisch C, Wilkinson J, Wolff R, Hooft L, Moons KGM, van Smeden M. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328. Update in: BMJ. 2021 Feb 3;372:n236. Erratum in: BMJ. 2020 Jun 3;369:m2204. PMID: 32265220; PMCID: PMC7222643.
  17. Beltrán-Corbellini Á, Chico-García JL, Martínez-Poles J, Rodríguez-Jorge F, Natera-Villalba E, Gómez-Corral J, Gómez-López A, Monreal E, Parra-Díaz P, Cortés-Cuevas JL, Galán JC, Fragola-Arnau C, Porta-Etessam J, Masjuan J, Alonso-Cánovas A. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study. Eur J Neurol. 2020 Sep;27(9):1738-1741. doi: 10.1111/ene.14273. Epub 2020 May 16. PMID: 32320508; PMCID: PMC7264557.
  18. Haehner A, Draf J, Dräger S, de With K, Hummel T. Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19. ORL J Otorhinolaryngol Relat Spec. 2020;82(4):175-180. doi: 10.1159/000509143. Epub 2020 Jun 11. PMID: 32526759; PMCID: PMC7360503.
  19. Hornuss D, Lange B, Schröter N, Rieg S, Kern WV, Wagner D. Anosmia in COVID-19 patients. Clin Microbiol Infect. 2020 Oct;26(10):1426-1427. doi: 10.1016/j.cmi.2020.05.017. Epub 2020 May 22. PMID: 32447049; PMCID: PMC7242197.
  20. Boscolo-Rizzo P, Borsetto D, Hopkins C, Polesel J. Challenges in interpreting the diagnostic performance of symptoms to predict COVID-19 status: The case of anosmia. Int Forum Allergy Rhinol. 2020 Sep;10(9):1113-1115. doi: 10.1002/alr.22650. Epub 2020 Jul 17. PMID: 32588537; PMCID: PMC7361777.
  21. Yan CH, Faraji F, Prajapati DP, Ostrander BT, DeConde AS. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831. doi: 10.1002/alr.22592. Epub 2020 Jun 7. PMID: 32329222; PMCID: PMC7264572.
  22. Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813. doi: 10.1002/alr.22579. Epub 2020 Jun 1. PMID: 32279441; PMCID: PMC7262089.
  23. Eliezer M, Hautefort C, Hamel AL, Verillaud B, Herman P, Houdart E, Eloit C. Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020 Jul 1;146(7):674-675. doi: 10.1001/jamaoto.2020.0832. PMID: 32267483.
  24. Mutiawati E, Fahriani M, Mamada SS, Fajar JK, Frediansyah A, Maliga HA, Ilmawan M, Emran TB, Ophinni Y, Ichsan I, Musadir N, Rabaan AA, Dhama K, Syahrul S, Nainu F, Harapan H. Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis. F1000Res. 2021 Jan 21;10:40. doi: 10.12688/f1000research.28393.1. PMID: 33824716; PMCID: PMC7993408.


Comments


Swift, Reliable, and studious. We aim to cherish the world by publishing precise knowledge.

  • asd
  • Brown University Library
  • University of Glasgow Library
  • University of Pennsylvania, Penn Library
  • University of Amsterdam Library
  • The University of British Columbia Library
  • UC Berkeley’s Library
  • MIT Libraries
  • Kings College London University
  • University of Texas Libraries
  • UNSW Sidney Library
  • The University of Hong Kong Libraries
  • UC Santa Barbara Library
  • University of Toronto Libraries
  • University of Oxford Library
  • Australian National University
  • ScienceOpen
  • UIC Library
  • KAUST University Library
  • Cardiff University Library
  • Ball State University Library
  • Duke University Library
  • Rutgers University Library
  • Air University Library
  • UNT University of North Texas
  • Washington Research Library Consortium
  • Penn State University Library
  • Georgetown Library
  • Princeton University Library
  • Science Gate
  • Internet Archive
  • WashingTon State University Library
  • Dimensions
  • Zenodo
  • OpenAire
  • Index Copernicus International
  • icmje
  •  International Scientific Indexing (ISI)
  • Sherpa Romeo
  • ResearchGate
  • Universidad De Lima
  • WorldCat
  • JCU Discovery
  • McGill
  • National University of Singepore Libraries
  • SearchIT
  • Scilit
  • SemantiScholar
  • Base Search
  • VU
  • KB
  • Publons
  • oaji
  • Harvard University
  • sjsu-library
  • UWLSearch
  • Florida Institute of Technology
  • CrossRef
  • LUBsearch
  • Universitat de Paris
  • Technical University of Denmark
  • ResearchBIB
  • Google Scholar
  • Microsoft Academic Search